10,856
Total Claims
$1.6M
Drug Cost
1,816
Beneficiaries
$855
Cost/Patient
Peer Comparison vs. 18,720 Cardiology providers
-44%
Cost per patient vs peers
$855 vs $1,524 avg
-5%
Brand preference vs peers
13.0% vs 13.7% avg
Brand vs Generic
87% generic
Brand: 1,410 claims · $1.3M
Generic: 9,446 claims · $234K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 781 | $867K |
| Rivaroxaban | 139 | $171K |
| Evolocumab | 119 | $88K |
| Sacubitril/Valsartan | 45 | $66K |
| Dronedarone Hcl | 36 | $41K |
| Alirocumab | 33 | $26K |
| Ezetimibe | 479 | $20K |
| Atorvastatin Calcium | 796 | $14K |
| Icosapent Ethyl | 28 | $13K |
| Losartan Potassium | 604 | $13K |
| Rosuvastatin Calcium | 586 | $12K |
| Amlodipine Besylate | 1,318 | $12K |
| Metoprolol Succinate | 522 | $11K |
| Evolocumab | 16 | $9,557 |
| Ranolazine | 70 | $8,328 |
Prescribing Profile
69
Unique Drugs
$1.1M
Patient Profile
74
Avg Age
53%
Female
1.38
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data